U.S. flag

An official website of the United States government

NM_000497.4(CYP11B1):c.811_812insAGAGGGAT (p.Ile271fs) AND Deficiency of steroid 11-beta-monooxygenase

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 5, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002309563.2

Allele description [Variation Report for NM_000497.4(CYP11B1):c.811_812insAGAGGGAT (p.Ile271fs)]

NM_000497.4(CYP11B1):c.811_812insAGAGGGAT (p.Ile271fs)

Genes:
LOC106799833:CYP11B1 recombination region [Gene]
CYP11B1:cytochrome P450 family 11 subfamily B member 1 [Gene - OMIM - HGNC]
Variant type:
Insertion
Cytogenetic location:
8q24.3
Genomic location:
Preferred name:
NM_000497.4(CYP11B1):c.811_812insAGAGGGAT (p.Ile271fs)
HGVS:
  • NC_000008.11:g.142876383_142876384insATCCCTCT
  • NG_007954.1:g.8437_8438insAGAGGGAT
  • NG_046132.1:g.2250_2251insATCCCTCT
  • NM_000497.4:c.811_812insAGAGGGATMANE SELECT
  • NM_001026213.1:c.811_812insAGAGGGAT
  • NP_000488.3:p.Ile271fs
  • NP_001021384.1:p.Ile271fs
  • NC_000008.10:g.143957799_143957800insATCCCTCT
Protein change:
I271fs
Molecular consequence:
  • NM_000497.4:c.811_812insAGAGGGAT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001026213.1:c.811_812insAGAGGGAT - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Deficiency of steroid 11-beta-monooxygenase (CYP11B1)
Synonyms:
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY; 11-beta-hydroxylase deficiency; Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008729; MedGen: C0268292; OMIM: 202010

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002603440Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2021))
Likely pathogenic
(Feb 5, 2022)
unknownclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Myriad Genetics, Inc., SCV002603440.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

NM_000497.3(CYP11B1):c.811_812ins8(I271Kfs*28) is expected to be pathogenic in the context of congenital adrenal hyperplasia, CYP11B1-related. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in CYP11B1, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2022